The largest community of pharma leaders

PROMETRIKA Announces New Leadership Team Member

CAMBRIDGE, Mass.–()–PROMETRIKA, LLC is proud to welcome Barry Mirrer as our new Head of Quality Assurance. Barry comes to PROMETRIKA with more than 15 years of experience in the development and management of quality systems in the biopharmaceutical industry. At PROMETRIKA, Barry will have responsibility for all aspects of quality and compliance.

A graduate of the Massachusetts Institute of Technology with a Master’s degree in Electrical Engineering and Computer Science, Barry began his professional career developing and managing systems and practices that dramatically improved quality and customer satisfaction in engineering software design. Pursuing his interests in process improvement and quality assurance, Barry has held positions of increasing responsibility in quality management for clinical research organizations serving the biopharmaceutical industry.

Prior to joining PROMETRIKA, Barry was Global Head, Quality Management for IQVIA, with responsibility for quality systems across the Real World & Analytics Solutions organization. In this role, Barry created and implemented a mission, vision, and strategy for quality management and integrated more than 200 procedures as the company grew from the merger of other entities. He has also developed and directed training programs to meet current industry standards.

Miganush Stepanians, PhD, President & CEO of PROMETRIKA, noted, “Barry’s background and expertise in the complexities of industry best practices and regulatory compliance will be an invaluable asset to PROMETRIKA. We look forward to working with him towards the further growth of the company.”

Founded in 2003 and based in Cambridge, Massachusetts, PROMETRIKA is a unique Clinical Research Organization, utilizing a collaborative approach to clinical development and execution with a close-knit, highly-experienced senior leadership team that remains involved throughout the duration of each trial. PROMETRIKA’s services include complete clinical operations and clinical trial management, data management, pharmacovigilance, biostatistics and programming, medical writing, and regulatory submissions.

Read More

Recent Articles

AVROBIO to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene...

Global Neurofibromatosis Treatment Drugs Market to Surpass US$ 21,223.7 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)-- #NeurofibromatosisTreatment--The Asia Pacific is expected to witness significant growth...

FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (GSK) (LSE/NYSE: GSK) today announced the US Food...

Novocure Honors Mesothelioma Day with Activities to Raise Awareness of Mesothelioma and Support the Community

ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced today initiatives to bring attention to...

Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Receives ADLT Status for Envisia Genomic...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.